[Changes in the prevalence of asthma in the Spanish cohort of the European Community Respiratory Health Survey (ECRHS-II)]
- PMID: 17692242
- DOI: 10.1016/s1579-2129(07)60098-6
[Changes in the prevalence of asthma in the Spanish cohort of the European Community Respiratory Health Survey (ECRHS-II)]
Erratum in
- Arch Bronconeumol. 2007 Oct;43(10):589
Abstract
Objective: The rise in the prevalence of asthma in the second half of the 20th century has not been evenly distributed according to recent surveys. We assessed changes in the prevalence of asthma after a period of 9 to 10 years in a cohort of young adults in the Spanish arm of the European Community Respiratory Health Survey (ECRHS).
Material and methods: The ECRHS-II is a multicenter cohort study taking place in 27 centers around Europe, with Spanish centers located in Albacete, Barcelona, Galdakao, Huelva, and Oviedo. The ECRHS questionnaire was administered to individuals who had participated in the first phase of the survey; spirometry and methacholine challenge tests were also performed according to the published protocol.
Results: Among new smokers, the prevalence of wheezing in the last 12 months increased from 10% to 33%, while the frequency of phlegm production rose from 8% to 22% (P< .05). In ex-smokers, the prevalences of wheezing and phlegm production decreased from 21% to 12% and from 15% to 8%, respectively (P< .05). Symptom prevalences remained similar for never smokers, although the frequency of diagnosed asthma rose from 4% to 7% (P< .05). After adjusting for smoking, age, sex, and center, we found no significant differences in the frequency of symptoms or asthma, even when the phrase bronchial hyperreactivity was included in the definition. However, the rate of reported asthma rose annually by 0.34% (95% confidence interval [CI], 0.20%-0.48%), while diagnosed asthma rose by 0.26% (95% CI, 0.13%-0.39%) and treated asthma by 0.16% (95% CI, 0.07%-0.25%).
Conclusions: Increased prevalence rates of asthma diagnosis and treatment have been detected, but the rates of reported symptoms have remained similar, consistent with the assumption that more persons are being classified as asthmatics.
Similar articles
-
[European study on asthma. Prevalence of bronchial hyperreactivity and asthma in young adults from 5 Spanish areas. Spanish Group of the European Study on Asthma].Med Clin (Barc). 1996 May 25;106(20):761-7. Med Clin (Barc). 1996. PMID: 8801394 Spanish.
-
[European Asthma Study. Identifying and treating young adults with epidemiological criteria for asthma in five areas of Spain. Spanish Group of the European Asthma Study].Arch Bronconeumol. 1999 May;35(5):223-8. doi: 10.1016/s0300-2896(15)30259-3. Arch Bronconeumol. 1999. PMID: 10378050 Spanish.
-
Risk factors for asthma in young adults. Spanish Group of the European Community Respiratory Health Survey.Eur Respir J. 1997 Nov;10(11):2490-4. doi: 10.1183/09031936.97.10112490. Eur Respir J. 1997. PMID: 9426084
-
The role of smoking in allergy and asthma: lessons from the ECRHS.Curr Allergy Asthma Rep. 2012 Jun;12(3):185-91. doi: 10.1007/s11882-012-0260-9. Curr Allergy Asthma Rep. 2012. PMID: 22528471 Review.
-
[Asthma concepts and epidemiological tools for prevalence researches].Rev Port Pneumol. 2004 Jul-Aug;10(4):319-29. Rev Port Pneumol. 2004. PMID: 15492877 Review. Portuguese.
Cited by
-
Effectiveness and Safety of Bronchial Thermoplasty in Severe Asthma in Clinical Practice in Spain.Biomed Hub. 2018 Nov 1;3(3):1-9. doi: 10.1159/000492075. eCollection 2018 Sep-Dec. Biomed Hub. 2018. PMID: 31988961 Free PMC article.
-
Asthma and COPD in Hospitalized COVID-19 Patients.Arch Bronconeumol (Engl Ed). 2020 Sep;56(9):604-606. doi: 10.1016/j.arbres.2020.05.007. Epub 2020 May 31. Arch Bronconeumol (Engl Ed). 2020. PMID: 32586704 Free PMC article. English, Spanish. No abstract available.
-
The association between asthma control, health care costs, and quality of life in France and Spain.BMC Pulm Med. 2013 Mar 22;13:15. doi: 10.1186/1471-2466-13-15. BMC Pulm Med. 2013. PMID: 23517484 Free PMC article.
-
A budget impact analysis of Spiromax(®) compared with Turbuhaler(®) for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions.Clinicoecon Outcomes Res. 2016 Sep 6;8:435-44. doi: 10.2147/CEOR.S111453. eCollection 2016. Clinicoecon Outcomes Res. 2016. PMID: 27660476 Free PMC article.
-
Level of Compliance with Spanish Guideline Recommendations in the Management of Asthma.J Asthma Allergy. 2024 Sep 16;17:879-887. doi: 10.2147/JAA.S433291. eCollection 2024. J Asthma Allergy. 2024. PMID: 39309478 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical